BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 29231865)

  • 1. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
    Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas.
    Chen N; Shao C; Li S; Wang Z; Qu Y; Gu W; Yu C; Ye L
    J Colloid Interface Sci; 2015 Nov; 457():27-34. PubMed ID: 26151564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
    Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
    Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for
    Zhan Y; Ehlerding EB; Shi S; Graves SA; Goel S; Engle JW; Liang J; Cai W
    J Biomed Nanotechnol; 2018 May; 14(5):900-909. PubMed ID: 29883560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
    Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
    ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
    Abbasi AZ; Prasad P; Cai P; He C; Foltz WD; Amini MA; Gordijo CR; Rauth AM; Wu XY
    J Control Release; 2015 Jul; 209():186-96. PubMed ID: 25908171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma.
    Lai J; Wang T; Wang H; Shi F; Gu W; Ye L
    Mikrochim Acta; 2018 Apr; 185(4):244. PubMed ID: 29610993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
    Chen N; Shao C; Qu Y; Li S; Gu W; Zheng T; Ye L; Yu C
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):19850-7. PubMed ID: 25335117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
    Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
    ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the sensitivity of
    Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
    Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
    [No Abstract]   [Full Text] [Related]  

  • 13. Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.
    Hu H; Dai A; Sun J; Li X; Gao F; Wu L; Fang Y; Yang H; An L; Wu H; Yang S
    Nanoscale; 2013 Nov; 5(21):10447-54. PubMed ID: 24057072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform.
    Ha TL; Kim HJ; Shin J; Im GH; Lee JW; Heo H; Yang J; Kang CM; Choe YS; Lee JH; Lee IS
    Chem Commun (Camb); 2011 Aug; 47(32):9176-8. PubMed ID: 21761053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese Oxide-Coated Carbon Nanotubes As Dual-Modality Lymph Mapping Agents for Photothermal Therapy of Tumor Metastasis.
    Wang S; Zhang Q; Yang P; Yu X; Huang LY; Shen S; Cai S
    ACS Appl Mater Interfaces; 2016 Feb; 8(6):3736-43. PubMed ID: 26653008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.
    Zheng Y; Zhang H; Hu Y; Bai L; Xue J
    Int J Nanomedicine; 2018; 13():6177-6188. PubMed ID: 30323598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile synthesis and functionalization of manganese oxide nanoparticles for targeted T1-weighted tumor MR imaging.
    Luo Y; Yang J; Li J; Yu Z; Zhang G; Shi X; Shen M
    Colloids Surf B Biointerfaces; 2015 Dec; 136():506-13. PubMed ID: 26454057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Magnetic Resonance Imaging and Modulation of Hypoxia with Multifunctional Hyaluronic Acid-MnO
    Fu C; Duan X; Cao M; Jiang S; Ban X; Guo N; Zhang F; Mao J; Huyan T; Shen J; Zhang LM
    Adv Healthc Mater; 2019 May; 8(10):e1900047. PubMed ID: 30920772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
    Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
    Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
    Cai X; Zhu Q; Zeng Y; Zeng Q; Chen X; Zhan Y
    Int J Nanomedicine; 2019; 14():8321-8344. PubMed ID: 31695370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.